VCKSX Mutual Fund

NAV$10.02

Fund Essentials - as of Mar 31, 2026

Net Assets
$15,939.74
Expense Ratio
1.95%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••

Performance

YTD+2.66%
1 Year-7.14%
3 Year+3.00%
5 Year-1.27%

Asset Allocation

Stocks: 99.17%
Cash: 0.83%

Top Holdings

View All →
TickerNameWeight
LMATLemaitre Vascular Inc5.91%
HEI.AHeico Corp. Cl. A4.92%
WSTWest Pharmaceutical Services Inc4.92%
TDYTeledyne Technologies Inc4.86%
HQYHealthequity4.31%
Top 10 Concentration: 44.02%Report Date: Mar 31, 2026
Download all 28 holdings for VCKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

VCKSX Mutual Fund Overview

VCKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class C) is managed by Virtus Investment Partners with $15,939.74 in net assets. VCKSX expense ratio is 1.95%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VCKSX performance shows a YTD return of 2.66%. The 1-year return is -7.14% and the 5-year return is -1.27%.

VCKSX top holdings include Lemaitre Vascular Inc (5.9%), Heico Corp. Cl. A (4.9%), West Pharmaceutical Services Inc (4.9%), Teledyne Technologies Inc (4.9%), Healthequity (4.3%). View all VCKSX holdings, sector breakdown, or dividend history.

VCKSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VCKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.